XBB. 1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants
COVID-19 vaccines have recently been updated with the spike protein of SARS-CoV-2 XBB.
1.5 subvariant alone, but their immunogenicity in humans has yet to be fully evaluated and …
1.5 subvariant alone, but their immunogenicity in humans has yet to be fully evaluated and …
[PDF][PDF] Implications for the EU/EEA of the spread of the SARS-CoV-2 Omicron XBB. 1.5 sub-lineage
TA Brief - 2023 - oficialmedia.com
Summary The XBB. 1.5 Omicron sub-lineage was first detected in samples in the United
States (US) in October 2022. This sub-lineage has been growing in proportion in the US and …
States (US) in October 2022. This sub-lineage has been growing in proportion in the US and …
[HTML][HTML] Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron variants
O Launay, R Gupta, T Machabert, E Konate… - 2023 - europepmc.org
We previously reported the safety and immunogenicity data from a randomized trial
comparing the monovalent (MV) recombinant protein Beta-variant (MVB. 1.351) and MV …
comparing the monovalent (MV) recombinant protein Beta-variant (MVB. 1.351) and MV …